Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 6

See more details

Referenced in 1 patents
Referenced in 1 Wikipedia pages
43 readers on Mendeley
  • Article usage
  • Citations to this article (245)

Advertisement

Research Article Free access | 10.1172/JCI1167

Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice.

M A Sussman, S Welch, N Cambon, R Klevitsky, T E Hewett, R Price, S A Witt, and T R Kimball

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Sussman, M. in: JCI | PubMed | Google Scholar

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Welch, S. in: JCI | PubMed | Google Scholar

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Cambon, N. in: JCI | PubMed | Google Scholar

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Klevitsky, R. in: JCI | PubMed | Google Scholar

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Hewett, T. in: JCI | PubMed | Google Scholar

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Price, R. in: JCI | PubMed | Google Scholar

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Witt, S. in: JCI | PubMed | Google Scholar

The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229, USA. sussman@heart.chmcc.org

Find articles by Kimball, T. in: JCI | PubMed | Google Scholar

Published January 1, 1998 - More info

Published in Volume 101, Issue 1 on January 1, 1998
J Clin Invest. 1998;101(1):51–61. https://doi.org/10.1172/JCI1167.
© 1998 The American Society for Clinical Investigation
Published January 1, 1998 - Version history
View PDF
Abstract

Loss of myofibril organization is a common feature of chronic dilated and progressive cardiomyopathy. To study how the heart compensates for myofibril degeneration, transgenic mice were created that undergo progressive loss of myofibrils after birth. Myofibril degeneration was induced by overexpression of tropomodulin, a component of the thin filament complex which determines and maintains sarcomeric actin filament length. The tropomodulin cDNA was placed under control of the alpha-myosin heavy chain gene promoter to overexpress tropomodulin specifically in the myocardium. Offspring with the most severe phenotype showed cardiomyopathic changes between 2 and 4 wk after birth. Hearts from these mice present characteristics consistent with dilated cardiomyopathy and a failed hypertrophic response. Histological analysis showed widespread loss of myofibril organization. Confocal microscopy of isolated cardiomyocytes revealed intense tropomodulin immunoreactivity in transgenic mice together with abnormal coincidence of tropomodulin and alpha-actinin reactivity at Z discs. Contractile function was compromised severely as determined by echocardiographic analyses and isolated Langendorff heart preparations. This novel experimentally induced cardiomyopathy will be useful for understanding dilated cardiomyopathy and the effect of thin filament-based myofibril degeneration upon cardiac structure and function.

Version history
  • Version 1 (January 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 6
  • Article usage
  • Citations to this article (245)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 1 Wikipedia pages
43 readers on Mendeley
See more details